3-(4-bromophenyl)-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(3-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(4-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;4-[4-[4-hydroxy-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-3-yl]phenyl]benzamide;1-methyl-3-[4-(3-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;1-methyl-3-[4-(4-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol

C147H124BrF2N31O11S2 — CID 158401254

IUPAC3-(4-bromophenyl)-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(3-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(4-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;4-[4-[4-hydroxy-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-3-yl]phenyl]benzamide;1-methyl-3-[4-(3-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;1-methyl-3-[4-(4-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol
SMILESCn1nc(-c2ccc(-c3ccc(C(N)=O)cc3)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3.Cn1nc(-c2ccc(-c3ccc(F)cc3)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3.Cn1nc(-c2ccc(-c3ccc(S(C)(=O)=O)cc3)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3.Cn1nc(-c2ccc(-c3cccc(F)c3)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3.Cn1nc(-c2ccc(-c3cccc(S(C)(=O)=O)c3)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3.Cn1nc(-c2ccc(Br)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3
InChIInChI=1S/C26H22N6O2.2C26H23N5O3S.2C25H20FN5O.C19H16BrN5O/c1-32-23(26-29-20-10-18-12-28-13-19(18)11-21(20)30-26)24(33)22(31-32)16-6-2-14(3-7-16)15-4-8-17(9-5-15)25(27)34;1-31-24(26-28-21-11-18-13-27-14-19(18)12-22(21)29-26)25(32)23(30-31)17-5-3-15(4-6-17)16-7-9-20(10-8-16)35(2,33)34;1-31-24(26-28-21-11-18-13-27-14-19(18)12-22(21)29-26)25(32)23(30-31)16-8-6-15(7-9-16)17-4-3-5-20(10-17)35(2,33)34;1-31-23(25-28-20-10-17-12-27-13-18(17)11-21(20)29-25)24(32)22(30-31)16-4-2-14(3-5-16)15-6-8-19(26)9-7-15;1-31-23(25-28-20-10-17-12-27-13-18(17)11-21(20)29-25)24(32)22(30-31)15-7-5-14(6-8-15)16-3-2-4-19(26)9-16;1-25-17(18(26)16(24-25)10-2-4-13(20)5-3-10)19-22-14-6-11-8-21-9-12(11)7-15(14)23-19/h2-11,28,33H,12-13H2,1H3,(H2,27,34)(H,29,30);2*3-12,27,32H,13-14H2,1-2H3,(H,28,29);2*2-11,27,32H,12-13H2,1H3,(H,28,29);2-7,21,26H,8-9H2,1H3,(H,22,23)
InChIKeyGYCYPANXGCZMMN-UHFFFAOYSA-N
MW2682.85 g/mol
LogP24.92
Rot. Bonds20

About 3-(4-bromophenyl)-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(3-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(4-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;4-[4-[4-hydroxy-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-3-yl]phenyl]benzamide;1-methyl-3-[4-(3-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;1-methyl-3-[4-(4-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol

3-(4-bromophenyl)-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(3-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(4-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;4-[4-[4-hydroxy-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-3-yl]phenyl]benzamide;1-methyl-3-[4-(3-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;1-methyl-3-[4-(4-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol (PubChem CID 158401254) has the molecular formula C147H124BrF2N31O11S2 and a molecular weight of 2682.85 g/mol. Its IUPAC name is 3-(4-bromophenyl)-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(3-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(4-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;4-[4-[4-hydroxy-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-3-yl]phenyl]benzamide;1-methyl-3-[4-(3-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;1-methyl-3-[4-(4-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol.

Molecular Properties

Compound Name3-(4-bromophenyl)-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(3-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(4-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;4-[4-[4-hydroxy-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-3-yl]phenyl]benzamide;1-methyl-3-[4-(3-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;1-methyl-3-[4-(4-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol
PubChem CID158401254
Molecular FormulaC147H124BrF2N31O11S2
Molecular Weight2682.85 g/mol
Exact Mass2679.87
IUPAC Name3-(4-bromophenyl)-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(3-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(4-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;4-[4-[4-hydroxy-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-3-yl]phenyl]benzamide;1-methyl-3-[4-(3-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;1-methyl-3-[4-(4-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol
SMILESCn1nc(-c2ccc(-c3ccc(C(N)=O)cc3)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3.Cn1nc(-c2ccc(-c3ccc(F)cc3)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3.Cn1nc(-c2ccc(-c3ccc(S(C)(=O)=O)cc3)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3.Cn1nc(-c2ccc(-c3cccc(F)c3)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3.Cn1nc(-c2ccc(-c3cccc(S(C)(=O)=O)c3)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3.Cn1nc(-c2ccc(Br)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3
InChIInChI=1S/C26H22N6O2.2C26H23N5O3S.2C25H20FN5O.C19H16BrN5O/c1-32-23(26-29-20-10-18-12-28-13-19(18)11-21(20)30-26)24(33)22(31-32)16-6-2-14(3-7-16)15-4-8-17(9-5-15)25(27)34;1-31-24(26-28-21-11-18-13-27-14-19(18)12-22(21)29-26)25(32)23(30-31)17-5-3-15(4-6-17)16-7-9-20(10-8-16)35(2,33)34;1-31-24(26-28-21-11-18-13-27-14-19(18)12-22(21)29-26)25(32)23(30-31)16-8-6-15(7-9-16)17-4-3-5-20(10-17)35(2,33)34;1-31-23(25-28-20-10-17-12-27-13-18(17)11-21(20)29-25)24(32)22(30-31)16-4-2-14(3-5-16)15-6-8-19(26)9-7-15;1-31-23(25-28-20-10-17-12-27-13-18(17)11-21(20)29-25)24(32)22(30-31)15-7-5-14(6-8-15)16-3-2-4-19(26)9-16;1-25-17(18(26)16(24-25)10-2-4-13(20)5-3-10)19-22-14-6-11-8-21-9-12(11)7-15(14)23-19/h2-11,28,33H,12-13H2,1H3,(H2,27,34)(H,29,30);2*3-12,27,32H,13-14H2,1-2H3,(H,28,29);2*2-11,27,32H,12-13H2,1H3,(H,28,29);2-7,21,26H,8-9H2,1H3,(H,22,23)
InChIKeyGYCYPANXGCZMMN-UHFFFAOYSA-N
XLogP24.92
TPSA583.93 Ų
H-Bond Donors19
H-Bond Acceptors35
Rotatable Bonds20
Heavy Atoms194
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002682.85
LogP ≤ 524.92
H-Bond Donors ≤ 519
H-Bond Acceptors ≤ 1035

Analyze 3-(4-bromophenyl)-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(3-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(4-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;4-[4-[4-hydroxy-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-3-yl]phenyl]benzamide;1-methyl-3-[4-(3-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;1-methyl-3-[4-(4-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-(4-bromophenyl)-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(3-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(4-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;4-[4-[4-hydroxy-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-3-yl]phenyl]benzamide;1-methyl-3-[4-(3-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;1-methyl-3-[4-(4-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol?
The IUPAC name of 3-(4-bromophenyl)-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(3-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(4-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;4-[4-[4-hydroxy-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-3-yl]phenyl]benzamide;1-methyl-3-[4-(3-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;1-methyl-3-[4-(4-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol (CID 158401254) is 3-(4-bromophenyl)-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(3-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(4-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;4-[4-[4-hydroxy-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-3-yl]phenyl]benzamide;1-methyl-3-[4-(3-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;1-methyl-3-[4-(4-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol.
What is the SMILES notation for 3-(4-bromophenyl)-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(3-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(4-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;4-[4-[4-hydroxy-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-3-yl]phenyl]benzamide;1-methyl-3-[4-(3-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;1-methyl-3-[4-(4-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol?
The canonical SMILES for 3-(4-bromophenyl)-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(3-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(4-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;4-[4-[4-hydroxy-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-3-yl]phenyl]benzamide;1-methyl-3-[4-(3-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;1-methyl-3-[4-(4-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol is Cn1nc(-c2ccc(-c3ccc(C(N)=O)cc3)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3.Cn1nc(-c2ccc(-c3ccc(F)cc3)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3.Cn1nc(-c2ccc(-c3ccc(S(C)(=O)=O)cc3)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3.Cn1nc(-c2ccc(-c3cccc(F)c3)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3.Cn1nc(-c2ccc(-c3cccc(S(C)(=O)=O)c3)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3.Cn1nc(-c2ccc(Br)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3.
What is the InChIKey of 3-(4-bromophenyl)-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(3-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(4-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;4-[4-[4-hydroxy-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-3-yl]phenyl]benzamide;1-methyl-3-[4-(3-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;1-methyl-3-[4-(4-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol?
The InChIKey is GYCYPANXGCZMMN-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H22N6O2.2C26H23N5O3S.2C25H20FN5O.C19H16BrN5O/c1-32-23(26-29-20-10-18-12-28-13-19(18)11-21(20)30-26)24(33)22(31-32)16-6-2-14(3-7-16)15-4-8-17(9-5-15)25(27)34;1-31-24(26-28-21-11-18-13-27-14-19(18)12-22(21)29-26)25(32)23(30-31)17-5-3-15(4-6-17)16-7-9-20(10-8-16)35(2,33)34;1-31-24(26-28-21-11-18-13-27-14-19(18)12-22(21)29-26)25(32)23(30-31)16-8-6-15(7-9-16)17-4-3-5-20(10-17)35(2,33)34;1-31-23(25-28-20-10-17-12-27-13-18(17)11-21(20)29-25)24(32)22(30-31)16-4-2-14(3-5-16)15-6-8-19(26)9-7-15;1-31-23(25-28-20-10-17-12-27-13-18(17)11-21(20)29-25)24(32)22(30-31)15-7-5-14(6-8-15)16-3-2-4-19(26)9-16;1-25-17(18(26)16(24-25)10-2-4-13(20)5-3-10)19-22-14-6-11-8-21-9-12(11)7-15(14)23-19/h2-11,28,33H,12-13H2,1H3,(H2,27,34)(H,29,30);2*3-12,27,32H,13-14H2,1-2H3,(H,28,29);2*2-11,27,32H,12-13H2,1H3,(H,28,29);2-7,21,26H,8-9H2,1H3,(H,22,23).
What are the key properties of 3-(4-bromophenyl)-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(3-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(4-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;4-[4-[4-hydroxy-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-3-yl]phenyl]benzamide;1-methyl-3-[4-(3-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;1-methyl-3-[4-(4-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol?
3-(4-bromophenyl)-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(3-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(4-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;4-[4-[4-hydroxy-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-3-yl]phenyl]benzamide;1-methyl-3-[4-(3-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;1-methyl-3-[4-(4-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol has a molecular weight of 2682.85 g/mol, XLogP of 24.92, 20 rotatable bonds, 19 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(4-bromophenyl)-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(3-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;3-[4-(4-fluorophenyl)phenyl]-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;4-[4-[4-hydroxy-1-methyl-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-3-yl]phenyl]benzamide;1-methyl-3-[4-(3-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol;1-methyl-3-[4-(4-methylsulfonylphenyl)phenyl]-5-(3,5,6,7-tetrahydropyrrolo[3,4-f]benzimidazol-2-yl)pyrazol-4-ol is sourced from PubChem (CID 158401254), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).